價格 | ¥269 | ¥382 | ¥659 |
包裝 | 5mg | 10mg | 25mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-23 |
中文名稱:去甲斑蝥素 | 英文名稱:(±)-Norcantharidin |
CAS:29745-04-8 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: ≥98% | 產(chǎn)品類別: 抑制劑 |
貨號: T5656 |
名稱 | (±)-Norcantharidin |
描述 | (±)-Norcantharidin (Endothall anhydride) is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers. |
細胞實驗 | Two human colon cancer cell lines, HCT116 and HT29, were used as model systems to investigate the anti-cancer molecular mechanism of NCTD. Cell cycle arrest and early/late apoptosis were analyzed by flow cytometry. The levels of EGFR, phospho-EGFR, c-Met, phospho-c-Met and other related proteins were quantified by western blot analysis[1] |
動物實驗 | The tumor xenograft model of human gallbladder carcinoma in nude mice in vivo was established with subcutaneous GBC-SD cells. The experimental mice were randomly divided into control, 5-FU, NCTD, and NCTD+5-FU groups which were given different treatments. Tumor growth in terms of size, growth curve, and inhibitory rate was evaluated. Cell cycle, apoptosis, and morphological changes of the xenografted tumors were assessed by flow cytometry and light/electron microscopy. The expression of the cell cycle-related proteins cyclin-D1 and p27 as well as the apoptosis-related proteins Bcl-2, Bax, and survivin were determined by the streptavidin-biotin complex (SABC) method and RT-PCR[2]. |
體內(nèi)活性 | NCTD可能是一種實惠且有效的候選化合物,以替代gefitinib來滿足癌癥患者的治療需求[1]。通過誘導凋亡和阻斷細胞周期,NCTD在體內(nèi)抑制裸鼠人類膽囊癌異種移植瘤的生長[2]。 |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 60 mg/mL (356.82 mM), Sonication is recommended. |
關鍵字 | (±) Norcantharidin | (±)Norcantharidin |
相關產(chǎn)品 | Lapatinib | Neratinib | Chalcone | Gefitinib | Erlotinib | Osimertinib | Erlotinib hydrochloride | Afatinib Dimaleate | Lidocaine Hydrochloride hydrate | Genistein | L-Ascorbic acid 2-phosphate trisodium | Khellin |
相關庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 抗癌上市藥物庫 | 抗癌活性化合物庫 | 激酶抑制劑庫 | 抗癌天然產(chǎn)物庫 | 天然產(chǎn)物庫 | 藥物功能重定位化合物庫 | 高通量篩選天然產(chǎn)物庫 | 抗感染天然產(chǎn)物庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.2651萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 化學試劑,生物活性小分子 | 經(jīng)營模式 | 貿(mào)易,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP6年
|
湖北威德利化學試劑有限公司
|
2024-11-18 | |
¥854 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2024-11-18 | |
詢價 |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2024-11-18 | |
詢價 |
VIP6年
|
陜西新天域生物科技有限公司
|
2024-11-18 | |
¥22000 |
VIP3年
|
湖北萬業(yè)眾誠化學試劑有限責任公司
|
2024-11-18 | |
¥3800 |
VIP9年
|
湖北威德利化學試劑有限公司
|
2024-11-18 | |
詢價 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2024-11-18 | |
¥10000 |
VIP12年
|
湖北威德利化學科技有限公司
|
2024-11-17 | |
詢價 |
VIP4年
|
武漢東康源科技有限公司
|
2024-11-15 | |
¥1275 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2024-11-14 |